Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell renal cell carcinomaDavid A. Braun, Toni K. Choueiri, Petra Ross‐Macdonald et al.|Nature Medicine|2020Cited by 1k
irRECIST for the Evaluation of Candidate Biomarkers of Response to Nivolumab in Metastatic Clear Cell Renal Cell Carcinoma: Analysis of a Phase II Prospective Clinical TrialJean‐Christophe Pignon, Sabina Signoretti, Opeyemi A. Jegede et al.|Clinical Cancer Research|2019Cited by 121
Expression of T-Cell Exhaustion Molecules and Human Endogenous Retroviruses as Predictive Biomarkers for Response to Nivolumab in Metastatic Clear Cell Renal Cell CarcinomaMiriam Ficial, Sabina Signoretti, Opeyemi A. Jegede et al.|Clinical Cancer Research|2020Cited by 81